CLINICAL INVESTIGATION OF SODIUM DICLOFENAC SUSTAINED-RELEASE SUPPOSITORIES

被引：16

作者：

NISHIHATA, T

KEIGAMI, M

KAMADA, A

FUJIMOTO, T

KAMIDE, S

TATSUMI, N

机构：

[1] SECOND OSAKA POLICE HOSP,DEPT ORTHOPAED SURG,OSAKA,JAPAN

[2] OSAKA UNIV,FAC PHARMACEUT SCI,OSAKA,JAPAN

[3] OSAKA UNIV,DEPT PHARM,OSAKA,JAPAN

[4] OSAKA UNIV,DEPT INTERNAL MED 1,OSAKA,JAPAN

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1988年 / 42卷 / 1-3期

关键词：

D O I：

10.1016/0378-5173(88)90182-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：251 / 256

页数：6

共 7 条

[1]

DEBOER AG, 1979, CLIN PHARMACOL THER, V26, P701

[2] ABSORPTION RATE AND BIOAVAILABILITY OF PROMETHAZINE FROM RECTAL AND ORAL DOSAGE FORMS [J].

MOOLENAAR, F ;

ENSING, JG ;

BOLHUIS, BG ;

VISSER, J .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1981, 9 (04) :353-357

[3] INVESTIGATION OF SUSTAINED-RELEASE SUPPOSITORY OF SODIUM DICLOFENAC IN HUMANS [J].

NISHIHATA, T ;

SUDHO, M ;

KAMADA, A ;

KEIGAMI, M ;

FUJIMOTO, T ;

KAMIDE, S ;

TATSUMI, N .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :181-186

[4] SUSTAINED-RELEASE OF SODIUM DICLOFENAC FROM SUPPOSITORY [J].

NISHIHATA, T ;

WADA, H ;

KAMADA, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (2-3) :245-253

[5]

RIESS W, 1978, SCAND J RHEUMATOL, P17

[6]

TORIS T, 1987, JPN J INFLAMMATION, V7, P289

[7]

YAGINUMA H, 1982, CHEM PHARM BULL, V30, P3302

← 1 →